Scientists say they have uncovering a potentially powerful genetic contributor to schizophrenia.
Scientists say they have broken new ground in the study of schizophrenia, uncovering a potentially powerful genetic contributor to the mental disorder and helping to explain why its symptoms of confused and delusional thinking most often reach a crisis state as a person nears the cusp of adulthood.
Genes associated with the function of the immune system have long been suspected in schizophrenia, but scientists have been at a loss to understand the nature of the link. A landmark study published Wednesday in the journal Nature provides the first rigorously tested insight into the biology behind any common psychiatric disorder. Researchers show that immune-related genetic variations linked to schizophrenia play a key role in prompting the “pruning” of brain connections in late adolescence.
That pruning of synapses — the connections among brain cells that proliferate with wild abandon throughout infancy and childhood — appears to play a key role in humans’ cognitive transition to adulthood. If that process were altered by a slight change in a gene, the scientists surmised, that transition may be disrupted, with disastrous results.
The study offers the first clear evidence of a neurobiological basis for a disease that places lifelong burdens on patients and their families. In addition to periodic episodes of delusional thinking, schizophrenics have difficulties with working memory, planning and executive function. More than 2 million Americans have a diagnosis of schizophrenia. The drugs available to treat it blunt some of its symptoms but do not touch the underlying cause.
Most Read Nation & World Stories
- Police seize guns in Snohomish County from man accused of 'preparing for race war'
- ‘Are you talking to me?’ Trump’s anger on impeachment erupts
- 1 dead after plane landing on Alaska island went off runway
- Gabbard fires back at Clinton suggestion she's Russia's pawn
- Mulvaney remarks enrage Trump advisers; Pelosi puts no timetable on impeach inquiry
The finding will not lead to new treatments soon, experts said, nor to widely available testing for individual risk. But the results provide researchers with their first biological handle on an ancient disorder whose cause has confounded modern science for generations. The finding also helps explain some other mysteries, including why the disorder often begins in adolescence or young adulthood.
The study was conducted by scientists from Harvard Medical School, Boston Children’s Hospital and the Broad Institute, a research center allied with Harvard and the Massachusetts Institute of Technology.
Scientists have long known that schizophrenia is a heritable disorder, as it tends to run powerfully through families. Recent advances in genetic research had turned up 108 regions along the genome where variations appeared to increase the risk of developing the disease.
But until now, scientists have been unable to link schizophrenia to specific genes or genetic variations, or show how the function of a specific gene or gene variant might lead to the brain and behavior abnormalities observed in schizophrenics.
In the study, geneticists and neurobiologists zeroed in on a genetic region that plays a key role in the immune system, but is also linked to the mental disorder. That region, called the Major Histocompatibility Complex, is diabolically sprawling and complex. Across its span lie genes that govern — in part, at least — the immune system’s ability to recognize and respond to disease and threats from foreign bodies. It also contains DNA variants that appear with regularity in schizophrenics.
After conducting genetic tests on nearly 65,000 people, the scientists followed a trail of clues to a group of genes in the MHC called C4 genes. They found that people with certain variants of C4 genes had unusually high odds of developing schizophrenia, even in the absence of other genetic risks.
To answer that question, the researchers genetically engineered mice that had the kinds of deficiencies in C4 that, in humans, is linked to schizophrenia.
They found that in mice with normal C4 genes, the genetic program they contained was particularly activated around late adolescence, initiating an editing process on the riot of synapses developed during infancy and childhood.
In mice genetically engineered to have the C4 deficiency, however, they found that the pruning process was markedly overactive. It removed synapses so ruthlessly that neural connections were likely to be missing throughout the brain.
With a better understanding of the molecular processes set in motion by errant genes, scientists can hope to develop more precise ways to treat, and perhaps even prevent, the brain changes seen in schizophrenia.